Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells-Reference-Cited by-同舟云学术

Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells

Published:2011-04 Issue:4 Volume:53 Page:1192-1205
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Schrader Jörg,Gordon-Walker Timothy T.,Aucott Rebecca L.,van Deemter Mariëlle,Quaas Alexander,Walsh Shaun,Benten Daniel,Forbes Stuart J.,Wells Rebecca G.,Iredale John P.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.24108/fullpdf

Reference38 articles.

1. Estimating the world cancer burden: Globocan 2000;Parkin;Int J Cancer,2001

2. Hepatocellular carcinoma in cirrhosis: incidence and risk factors;Fattovich;Gastroenterology,2004

3. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography;Masuzaki;HEPATOLOGY,2009

4. Assessing liver tumor stiffness by transient elastography;Masuzaki;Hepatol Int,2007

5. Can cancer be reversed by engineering the tumor microenvironment?;Ingber;Semin Cancer Biol,2008

Cited by 554 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of calcium concentration on metastasis of hepatocellular carcinoma cells cultured in alginate gel beads;Colloids and Surfaces B: Biointerfaces;2025-01

2. Matrix stiffening facilitates stemness of liver cancer stem cells by YAP activation and BMF inhibition;Biomaterials Advances;2024-10

3. Exploiting mechanoregulation via FAK/YAP to overcome platinum resistance in ovarian cancer;Biomedicine & Pharmacotherapy;2024-10

4. High Extracellular Matrix Stiffness Promotes the Metastasis of Nasopharyngeal Carcinoma through STAT3/FGF1 Positive Feedback Regulation Activated by JAK2;Precision Medicine and Engineering;2024-09

5. Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes;Clinical and Translational Medicine;2024-09